Literature DB >> 10201991

Bystander virus infection prolongs activated T cell survival.

T Mitchell1, J Kappler, P Marrack.   

Abstract

In animals, T cells often die rapidly after activation, unless activation occurs in the presence of inflammatory factors. To understand how such activated cells survive to participate in immune responses, we studied the effects of viral infection on T cells responding to an unrelated superantigen. Normal T cells activated by superantigen in uninfected mice died as a result of their activation, whereas T cells that were activated during vaccinia infection survived longer in vivo and in culture. This bystander effect of viral infection on activated T cells was independent of effects on the magnitude of the initial T cell response, on induction of Bcl-2 and Bcl-x, on T cell proliferation, and on Fas killing. The failure of such effects to predict the fate of activated T cells in vivo indicates that virus infections shape T cell responses via mechanisms that differ from those described previously. These mechanisms may contribute to the ability of viral infections to induce autoimmunity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10201991

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  33 in total

1.  Activation changes the spectrum but not the diversity of genes expressed by T cells.

Authors:  T K Teague; D Hildeman; R M Kedl; T Mitchell; W Rees; B C Schaefer; J Bender; J Kappler; P Marrack
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

Review 2.  T cell apoptosis and reactive oxygen species.

Authors:  David A Hildeman; Thomas Mitchell; John Kappler; Philippa Marrack
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

3.  Constitutive association of the proapoptotic protein Bim with Bcl-2-related proteins on mitochondria in T cells.

Authors:  Yanan Zhu; Bradley J Swanson; Michael Wang; David A Hildeman; Brian C Schaefer; Xinqi Liu; Hiroyuki Suzuki; Katsuyoshi Mihara; John Kappler; Philippa Marrack
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-10       Impact factor: 11.205

Review 4.  Apoptosis and the homeostatic control of immune responses.

Authors:  David Hildeman; Trine Jorgensen; John Kappler; Philippa Marrack
Journal:  Curr Opin Immunol       Date:  2007-07-20       Impact factor: 7.486

5.  Increased lymphocyte apoptosis in mouse models of colitis upon ABT-737 treatment is dependent upon BIM expression.

Authors:  C Lutz; M Mozaffari; V Tosevski; M Caj; P Cippà; B L McRae; C L Graff; G Rogler; M Fried; M Hausmann
Journal:  Clin Exp Immunol       Date:  2015-05-19       Impact factor: 4.330

6.  Bim is required for T-cell allogeneic responses and graft-versus-host disease in vivo.

Authors:  Yu Yu; Jing Yu; Cristina Iclozan; Kane Kaosaard; Claudio Anasetti; Xue-Zhong Yu
Journal:  Am J Blood Res       Date:  2012-01-01

7.  Cutting Edge: Limiting amounts of IL-7 do not control contraction of CD4+ T cell responses.

Authors:  Pulak Tripathi; Thomas C Mitchell; Fred Finkelman; David A Hildeman
Journal:  J Immunol       Date:  2007-04-01       Impact factor: 5.422

8.  All-trans-retinoic acid and polyriboinosinic : polyribocytidylic acid in combination potentiate specific antibody production and cell-mediated immunity.

Authors:  K L DeCicco; J D Youngdahl; A C Ross
Journal:  Immunology       Date:  2001-11       Impact factor: 7.397

9.  Control of Bcl-2 expression by reactive oxygen species.

Authors:  David A Hildeman; Thomas Mitchell; Bruce Aronow; Sara Wojciechowski; John Kappler; Philippa Marrack
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

10.  IL-10/Janus kinase/signal transducer and activator of transcription 3 signaling dysregulates Bim expression in autoimmune lymphoproliferative syndrome.

Authors:  Omar Niss; Allyson Sholl; Jack J Bleesing; David A Hildeman
Journal:  J Allergy Clin Immunol       Date:  2014-08-28       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.